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Abstract
Background: Frailty and sarcopenia are common amongst hospitalised older people and associated with poor
healthcare outcomes. Widely recognised tools for their identification are the Fried Frailty Phenotype, its self-report
version the FRAIL Scale, and the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. We
studied the feasibility of using these tools in a hospital setting of acute wards for older people.
Methods: Patients aged 70+ years admitted to acute wards at one English hospital were prospectively recruited.
The Fried Frailty Phenotype was assessed through measured grip strength, gait speed and questions on unintentional
weight loss, exhaustion and physical activity. The 5-item self-reported FRAIL scale questionnaire covering the same
domains was completed. Agreement between the two tools was reported using the Cohen kappa statistic. The
EWGSOP criteria (gait speed, grip strength and muscle mass) were assessed by additional bedside measurement
of muscle mass with bioelectrical impedance.
Results: Two hundred thirty three participants (median age 80 years, 60% men) were recruited. Most (221, 95%)
had their grip strength measured: 4 (2%) were unable and data were missing for 8 (3%). Only 70 (30%) completed
the gait speed assessment: 153 (66%) were unable with missing data on 10 (4%). 113 (49%) participants had the
bioelectrical impedance assessment. Muscle mass measurement was not possible for 84 (36%) participants: 25 patients
declined, 21 patients were unavailable, 22 results were technically invalid, and 16 had clinical contra-indications. Data
on 36 (15%) were missing.
Considering inability to complete grip strength or gait speed assessments as low values, data for the Fried Frailty Phenotype
was available for 218 (94%) of participants; frailty was identified in 105 (48%). 230 (99%) patients completed the
FRAIL scale; frailty was identified among 77 (34%). There was moderate agreement between the two frailty tools
(Kappa value of 0.46, 95%CI: 0.34 to 0.58). Complete data for the EWGOSP criteria were only available for 124
(53%) patients of whom 40 (32%) had sarcopenia.
Conclusion: It was feasible to measure grip strength and complete the FRAIL scale among older inpatients in
hospital. Measuring gait speed and muscle mass to identify sarcopenia was challenging in the acute setting.
Trial registration: ISRCTN registry (ID ISRCTN16391145) on 30.12.14.
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Background
Frailty (multi-system impairment associated with increased
vulnerability to stressors) and sarcopenia (muscle loss,
weakness and reduced muscle function associated with age-
ing) are both associated with adverse health outcomes and
admission to hospital [1, 2]. Sarcopenia has been recently
recognized in the International Classification of Diseases
(ICD-10) as a condition that should be diagnosed in older
populations [3]. There is also increasing recognition of the
importance of identifying frailty, but identifying these com-
mon conditions is neither routine nor standardised in the
in-patient hospital setting [4, 5]. This is an important area
to address in view of the prevalence, reversibility, and prog-
nostic value of these two conditions [6].
There are many reported objective and subjective frailty
measurement methods with the Fried Frailty Phenotype a
widely used tool to identify frailty and reported in 70% of
published papers [7]. A recent survey of 388 clinicians
from 44 countries reported that the Fried Frailty Phenotype
(27%), gait speed assessment (44%), and the Clinical Frailty
Scale (34%) are among the most widely used frailty tools
[8]. The five item self-report frailty tool “FRAIL scale” de-
veloped from the Fried Frailty Phenotype does not require
physical measurements of grip strength or gait speed [9]
and is recommended by the International Academy on Nu-
trition and Aging for use in daily clinical practice [10, 11].
The European Working Group in Sarcopenia in Older
People (EWGSOP) algorithm based on physical mea-
surements of gait speed, grip strength and muscle mass
is widely recognised for the diagnosis of sarcopenia in
clinical settings including hospitals [12]. Validated
questionnaire-based screening methods for sarcopenia
such as the SARC-F questionnaire, are more suitable
for screening to detect those at-risk of sarcopenia in
primary care settings [13, 14].
It has been suggested that most of the definitions and
tools to measure frailty and sarcopenia are more suited to
research studies than wider clinical practice [15]. Recent
work in the UK reported that it was feasible and
acceptable to routinely measure grip strength of older
people (70+ years) in hospital [16]. Jadczak et al.
reported that use of the FRAIL scale was feasible in
hospitalised frail older adults [17]. However, no study
has yet investigated the feasibility of assessing both syn-
dromes together in clinical practice. The aim of this
study was to assess whether it is feasible to assess both
frailty and sarcopenia, with a focus on the physical
measurements central to the Fried Frailty Phenotype
and EWGSOP criteria, among older people in hospital.
Methods
Study design and setting
This cross-sectional prospective study was part of a
larger study of mealtime volunteers [18].
Participants
Patients aged 70 years and over admitted as acute admis-
sions to one large English hospital were eligible. Patients
were recruited prospectively over a 2-year period from
March 2014 to March 2016. Patients were excluded if
they were receiving artificial nutrition (enteral or paren-
teral), nursed in a side room, on an end of life pathway
or unable to consent. All participants gave informed,
written consent.
Data collection
Demographic data including date of birth, gender, mari-
tal status and usual living arrangements were abstracted
from participants’ clinical records. Active co-morbidities
were obtained from medical records and used to calcu-
late the Charlson Comorbidity Index. Participants’ regu-
lar prescribed medication was determined from the
computerised prescribing system on the day of their
inclusion into the study. Cognition and mood were
assessed using the Mini Mental State Examination
(MMSE) (a score of < 24/30 indicates cognitive impair-
ment) [19] and the 15 item Geriatric Depression Scale
(GDS) (a score > 5 indicates that depression is likely)
[20]. The most recent Body Mass Index (BMI) was
abstracted from the clinical records. Physical activity
was measured using the Physical Activity Scale for the
Elderly (PASE) questionnaire which assesses the duration,
frequency, exertion level, and amount of physical activity
undertaken over a 7 day period by individuals 65 years
and older [21]. Activities of Daily Living (ADL) were mea-
sured using the 11 –item Modified Barthel Index [22].
Length of hospital stay, discharge destination, re-
admissions and death after 6 months were abstracted
from clinical records.
Assessment of frailty
Frailty was measured using the Fried Frailty Phenotype
and the FRAIL scale.
The Fried Frailty Phenotype identifies frailty by the
presence of three or more of self-reported weight loss of
>10lbs (4.5 kg) in the last year, exhaustion, low physical
activity, slow gait speed and weak grip strength [23].
Exhaustion was determined by self-report of feeling that
“in the last week, everything was an effort or I could not
get going” for three or more days. Physical activity level
was considered low if the participant’s PASE score was
in the lowest quintile, based on age and gender. Ma-
ximum grip strength was measured using a Jamar dyna-
mometer and standardised protocol [24]. Low grip
strength was defined as < 20 kg (kg) for women and < 30 kg
for men [12]. Normal gait was timed over a 4m course
and low gait speed defined as < 0.8m/second (m/s) [12].
Usual practice in published studies of reporting an inability
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to complete grip strength or gait speed measurement as
low values was followed [25, 26].
The FRAIL scale includes 5 questions assessing
fatigue, resistance, ambulation, illness and loss of weight
[27]. Each question scores one point with frailty identified
if participants score 3–5 points; 1–2 points represents
pre-frailty and 0 points a robust health status similar to
the Fried Frailty Phenotype.
Assessment of sarcopenia
The EWGSOP criteria of normal gait speed and grip
strength were previously measured as outlined above.
Muscle mass was measured using a portable bioelectrical
impedance machine (ImpediMedSFB7), a simple, non-
invasive technique. Skeletal muscle mass was calculated
using Janssen’s formula and considered to be low when
the skeletal muscle index was below the cut-off values vali-
dated in older people: SMI < 8.87 kg/m2 and < 6.67 kg/m2
in men and women, respectively [28].
Data analysis
The focus of this study was on the physical measure-
ments of frailty and sarcopenia criteria including grip
strength, gait speed, and muscle mass. The primary out-
come was the proportion of patients who a) had per-
formed each measurement, b) were unable to complete
them or c) had missing data. The analysis was mainly
descriptive. Counts and percentages were reported for
categorical variables. The median and inter-quartile
range were used to summarise all continuous variables,
none of which were normally distributed. The Kappa
statistic was used to assess agreement between the Fried
Frailty Phenotype and FRAIL Scale, for which 95% confi-
dence intervals (95% CI) were estimated. Tests of statis-
tical significance were not carried out due to the
descriptive nature of the analysis. All statistical analyses
were performed in Microsoft Excel 2003 (Microsoft
Corporation, Redmond, WA) and SPSS version 24
(SPSS software, IBM Corporation, Armonk, NY).
Results
Participants’ characteristics
Two hundred thirty three participants (median age 80
years, 60% men) were recruited to the study (Table 1).
Most (94%) participants lived in their own home and
half were married. The median number of comorbidities
and the median Charlson Comorbidity Index score was
5, with a median of 8 medications per patient. Median
cognition, mood and physical function (ADL) were
within normal values. The median length of stay was 10
days, and most participants (77%) were discharged to
their usual residence. Only 3% of participants died
during the following 6 months.
Feasibility of frailty and sarcopenia assessment
Two hundred twenty one of the 233 participants (95%)
completed the grip strength measurement and 157
(67%) had low grip strength (Table 2). Only 4 (2%) par-
ticipants were unable to complete the measurement and
data were missing for 8 (3%). However, the majority of
participants (153, 66%) were unable to undertake the
gait speed assessment with missing data for a further 10
(4%). Among the 70 (30%) who were able to walk four
metres, 27 had a slow gait speed and 43 had normal gait
values. 113 (49%) participants completed the bioelec-
trical impedance assessment, of whom 66 had low
values. 84 (36%) of participants did not complete the
muscle mass assessment test for different reasons
including: patient declined (25, 30%), technical difficul-
ties with the machine (22, 26%), clinical contraindication
(16, 19%), and patient unavailable, for example engaged
Table 1 Participants’ demographic and clinical characteristics
Participants (n = 233)
Age 80 (75,86)
Gender, n (%)
Male 139 (60)
Female 94 (40)
Marital status, n (%)
Single or Divorced/Separated 33 (14)
Married or Cohabiting 114 (49)
Widowed 86 (37)
Usual residence, n (%)
Private home 220 (94)
Warden-supported housing 8 (3)
Nursing / Care home 5 (4)
Number of comorbidities (n = 196, 84.1%) 5 (3,7)
Charlson Comorbidity Index 5 (4,7)
Number of medications (n = 196, 84.1%) 8 (6,11)
BMI (n = 232, 99.6%) 25.8 (22.6,28.6)
MMSE (n = 232, 99.6%) 28 (25,29)
GDS (n = 231, 99.1%) 3 (2,5)
PASE 51 (25, 107.5)
Barthel 87 (70,100)
Length of stay (n = 226, 97.0%) 10 (4,19)
Discharge destination, n (%)
Usual residence 174 (77)
New care home 19 (8)
Rehabilitation 19 (8)
Another hospital 8 (4)
n number of participants (stated for variables where less than complete data
was observed), % percentage; Summary statistics are median and inter-quartile
range, unless otherwise stated. BMI Body Mass Index, MMSE Mini Mental State
Examination, GDS Geriatric Depression Scale, PASE Physical Activity Scale for
the Elderly
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in clinical activities (21, 25%). Missing data for the bio-
electrical impedance assessment was recorded in 15%.
The Fried Frailty Phenotype was assessed in 218/233
(94%), considering the inability to complete the grip
strength or the gait speed measurement as a low value.
230/233 (99%) participants were able to complete the
self-reported Frail scale questionnaire. Data for sarcopenia
assessment were available for 124/233 (53%) patients only,
reflecting the difficulty with measuring muscle mass in
this group.
Prevalence of frailty and sarcopenia
The Fried Frailty Phenotype identified 105/218 (48%)
participants as frail, (Table 3) while the FRAIL scale
identified only 77/230 (34%) patients as frail. 46% of pa-
tients were found to be pre-frail using both tools. How-
ever, 6 and 20% of patients were found robust using the
Fried Frailty Phenotype and FRAIL scale, respectively.
There was moderate agreement between the Fried
Frailty Phenotype and FRAIL scale (Kappa value of 0.46,
95%CI: 0.34 to 0.58).
The EWGSOP criteria identified 40/124 (32%) patients
with sarcopenia among those who completed the bio-
electrical impedance muscle mass assessment. There
was only slight agreement between Fried Frailty Pheno-
type and sarcopenia (Kappa of 0.14, 95% CI: 0 to 0.33).
60 (43%) patients were found to have frailty using both
the Fried frailty phenotype and FRAIL scale, and 20
(14%) patients had both frailty (using either tool) and
sarcopenia see Fig. 1.
Discussion
The aim of this study was to assess whether it is feasible
to identify frailty and sarcopenia amongst older people
in hospital using the measurements required to under-
pin the widely validated Fried Frailty Phenotype and
EWGSOP criteria. It was feasible to measure grip
strength in most (95%) participants, but we could mea-
sure gait speed in only 30% and muscle mass in only
50% of participants even using bedside techniques.
Research evidence supports considering inability to
complete grip strength and gait speed assessment as low
values, and so frailty could be identified using the Fried
Frailty Phenotype. However such evidence is unavailable
for muscle mass measurement, so sarcopenia was chal-
lenging to assess in this hospital population using the
EWGSOP criteria. The prevalence of frailty in this group
was 34% (using the FRAIL Scale completed by 99% parti-
cipants) and 48% (by the Fried Frailty Phenotype com-
pleted by 92% participants). The prevalence of sarcopenia
Table 2 Completion of physical assessments
Normal Low Missing /no reason given Unable /declined
Grip strength 64 (28%) 157 (67%) 8 (3%)a 4 (2%)a
Gait speed 43 (18%) 27 (12%) 10 (4%)a 153 (66%)a
Muscle mass 47 (21%) 66 (28%) 36 (15%)a 84 (36%)ab
aSubjects for whom the assessment was not completed (missing/no reason given/unable/declined) comprised: grip strength - 6 female, 6 male; gait speed
measurements - 77 female, 86 male; and muscle mass measurements - 47 female, 73 male
bPatients declined n = 25, technical difficulty with machine n = 22, patient unavailable n = 21, contraindication (pacemaker, leg ulcers, etc.) n = 16
Table 3 Prevalence of frailty and sarcopenia
n (%)
Fried Frailty Score (n = 218)
Not frail (0) 12 (6)
Pre-frail (1 to 2) 101 (46)
Frail (3 and over) 105 (48)
FRAIL scale (n = 230)
Not frail (0) 47 (20)
Pre-frail (1 to 2) 106 (46)
Frail (3 and over) 77 (34)
Sarcopenia EWGOSP (n = 124)
NO 84 (68)
Yes 40 (32)
Fig. 1 A Venn diagram showing the overlap between the two
different frailty criteria and sarcopenia
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was 32% among those for whom data were available (53%
participants).
High levels of completion of grip strength measure-
ment have also been reported in a Danish study of 52
acute medical inpatients (mean age 78 years) [29] and
among 811 UK acute medical patients aged 70+ years
[15]. Confusion, dementia, patient refusal, severe acute
illness, aggressive patients, and severe arthritis were
among the reported reasons for inability to measure grip
strength [16]. Low grip strength was found in 71% of
patients in our study which is similar to that reported by
other studies [16, 30].
Gait speed is potentially easy to measure and is not
limited to a specific health care discipline [15, 31]. How-
ever, measuring gait speed among older inpatients in our
study was challenging and only 30% of our participants
were able to walk four metres. North American studies
of 35 patients aged 65+ in the Emergency Department
and 322 older medical inpatients (mean age 76 years) re-
ported 60 and 64% completion rates respectively [32, 33].
An Italian study of 103 hospital inpatients (mean age 84
years) reported that 22.3% were unable to perform either
gait speed or handgrip measurements [34].
A recent international survey of 255 clinicians from 55
countries reported that 58% of clinicians that measure
muscle mass in their practice use anthropometric data
(body mass index, calf circumference, mid-upper arm
circumference and skinfold thickness) and 46% use
dual-energy X-ray absorptiometry (DXA) [35]. However,
anthropometric measures are prone to error and less
suitable for assessing muscle mass in older people [36]
while inpatients may find it difficult to undergo DXA
[37] which also has associated costs and requirement for
trained assessors and equipment limiting routine use
[38]. Bioelectrical impedance analysis is suggested for
muscle mass assessment in primary care setting [39] but
in this study bioelectrical impedance was only feasible
among half of older inpatients. It can be contraindicated
(examples include leg ulcers, pacemaker), challenging
due to patient factors (unavailability or declining) or for
technical reasons (rejected or invalid readings), and is
sensitive to subjects’ hydration and recent activity [40].
In our study patient factors (decline, unavailable) and
clinical/technical factors were fairly equally responsible
for lack of muscle mass measurement. Other studies of
sarcopenia in hospital inpatients reported higher com-
pletion with around 58–90% participants able to have bio-
electrical impedance assessment [41, 42]. These studies
recruited included elective admissions and younger
patients and had a shorter median length of stay,
which could imply those participants were more able
to comply with the assessment. Technical problems
could be minimised by regular calibration of the machines.
Patient factors could be addressed by increasing public
awareness of sarcopenia. The guidelines for the diagno-
sis of sarcopenia (EWGSOP2) have recently been up-
dated. They now recommend case-finding using a brief
questionnaire such as the SARC-F [43], and then focus
on low muscle strength as the key characteristic of sar-
copenia with low muscle mass as a confirmatory factor.
Low physical performance such as slow gait speed indi-
cates severe sarcopenia. This update should improve
the diagnosis of sarcopenia among hospitalised older
patients similar to those in this study.
We found that it was feasible to assess frailty amongst
older hospital patients using the Fried Frailty Phenotype
(94%) and the FRAIL scale (99%). The Fried Frailty
Phenotype can take up to 20 min to complete with a
trained assessor while the FRAIL scale is a simple tool
that takes up to 5 min to complete without the need for
a trained assessor [44]. The Fried Frailty Phenotype has
good construct validity [23], convergent validity [45],
concurrent validity [46] and predictive validity [47] for
assessing frailty. It has also been shown that the tool has
good sensitivity to change following an intervention in
frail patients [48]. There is evidence that FRAIL scale
has an acceptable validity and reliability [27, 49, 50] and
that it has similar predictive accuracy to the Fried Frailty
Phenotype, in keeping with the moderate agreement
reported in this study.
In our cohort of acutely unwell older people, the
prevalence of frailty was 48% assessed by the Fried
Frailty Phenotype, and 34% by the FRAIL scale, consis-
tent with other studies of hospital patients such as a
study of 495 patients in Canada which reported 43% to
be frail [51]. The difference between the scales may
reflect the objective measurements in the Fried and the
subjective opinion of participants in the FRAIL scale.
Sarcopenia according to the EWGSOP criteria was iden-
tified among 33% of the participants able to complete
the assessments. Other studies using the EWGSOP cri-
teria and bioelectrical impedance have reported sarcope-
nia among 41% male and 32% female Portuguese
hospital patients aged > 65 years [41], 21.4% of Italian
acutely unwell patients aged > 65 years [34] and 25% of
German acute medical inpatients (mean age 83) [52].
However, the challenges of measuring muscle mass
among hospitalised older people make it difficult to
draw conclusive estimates of the prevalence of sarco-
penia among this population.
Strengths and limitations
A small team of trained researchers conducted all the
assessments using standardised protocols and calibrated
instruments whose accuracy was checked. The partici-
pants were well described and typical of a geriatric
inpatient population with a median of 5 comorbidities,
mostly living in their own homes. However, there were
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limitations to the study. The majority of participants
were discharged home after a median stay of 10 days
with a low mortality rate suggesting that this was a less
ill group, which may reflect the need for informed con-
sent to enter the study. Therefore, the prevalence of
frailty and sarcopenia of this in-patient group may have
been under-estimated. We considered inability to per-
form grip strength and gait speed as indicative of poor
function as suggested in the literature, which may also
have impacted the prevalence values reported here. This
sample of participants from one hospital also had little
ethnic diversity. We specifically evaluated the Fried
Frailty Phenotype, FRAIL Scale and EWGSOP tools
but additional comparison of other tools such as the
Clinical Frailty Scale and SARC-F tool for screening
sarcopenia would be helpful for future studies, which
should investigate the feasibility of clinical staff com-
pleting the assessments to improve the generalisability
of the results.
Conclusion
This study examined the feasibility of assessing frailty
and sarcopenia in hospitalised older people using the
measurements required to underpin the widely validated
Fried Frailty Phenotype and EWGSOP criteria. Measu-
ring grip strength was feasible and almost all partici-
pants completed this assessment. Measuring gait speed
and muscle mass among older acutely unwell patients
was difficult and many were unable to complete these
assessments. Imputing the inability to complete gait
speed and grip strength assessments as low values, we
were able to report the prevalence of frailty using the
Fried Frailty Phenotype. The FRAIL scale was completed
by 99% participants with moderate agreement between
the two frailty measures. The difficulty of assessing muscle
mass using bioelectrical impedance, made the identifica-
tion of sarcopenia in this acute setting challenging. The
results of this study support the updated EWGSOP2
guidelines with a focus on muscle strength as the key
characteristic of sarcopenia.
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